rss
08-24-2016, 08:58 PM
Why are EpiPens so expensive, and why is everyone so mad about it?
http://i.amz.mshcdn.com/DZIeMx5l6kgNKMcTmeo1Y9D1QP0=/575x323/https%3A%2F%2Fblueprint-api-production.s3.amazonaws.com%2Fuploads%2Fcard%2Fima ge%2F189108%2FGettyImages-118451569.jpghttp://a.amz.mshcdn.com/assets/feed-tw-f7c0a094d16b7ee7c91a1e50839a8e00.jpg (http://twitter.com/share?via=Mashable&text=Why+are+EpiPens+so+expensive%2C+and+why+is+ev eryone+so+mad+about+it%3F&url=http%3A%2F%2Fmashable.com%2F2016%2F08%2F24%2Fe pipens-mylan-price-hike%2F%3Futm_campaign%3DMash-Prod-RSS-Feedburner-All-Partial%26utm_cid%3DMash-Prod-RSS-Feedburner-All-Partial)http://a.amz.mshcdn.com/assets/feed-fb-c0a21e8841794479b8086c32c6f24ba1.jpg (http://www.facebook.com/sharer.php?u=http%3A%2F%2Fmashable.com%2F2016%2F08 %2F24%2Fepipens-mylan-price-hike%2F%3Futm_campaign%3DMash-Prod-RSS-Feedburner-All-Partial%26utm_cid%3DMash-Prod-RSS-Feedburner-All-Partial&src=sp)
Over the past few weeks, EpiPens have slowly overtaken the news. So what is going on with them exactly?*
What's happening with EpiPens?*
Last year, Bloomberg broke the story (http://www.bloomberg.com/news/articles/2015-09-23/how-marketing-turned-the-epipen-into-a-billion-dollar-business) that the pharmaceutical company Mylan had turned EpiPens into a cash cow of a business since it bought the product in 2007. In the past few weeks, those claims have come back to public attention.*
Mylan, a huge international pharmaceutical company, has slowly raised the price of EpiPens from an average of $50 in 2007 to more than $300 today (http://www.slate.com/articles/health_and_science/moneybox/2016/07/epipen_costs_have_soared_450_percent_in_the_past_1 2_years_for_**_good_reason.html). Sold only in two-packs —*a**ther change in the past decade — EpiPens can cost (http://www.mylan.com/en/products/product-catalog/product-profile-page?id=6749373C-9FB4-4E2B-A856-3771B31F68F3) as much as $600.* Read more... (http://mashable.com/2016/08/24/epipens-mylan-price-hike/?utm_campaign=Mash-Prod-RSS-Feedburner-All-Partial&utm_cid=Mash-Prod-RSS-Feedburner-All-Partial)
More about Business (http://mashable.com/business/?utm_campaign=Mash-Prod-RSS-Feedburner-All-Partial&utm_cid=Mash-Prod-RSS-Feedburner-All-Partial), Martin Shkreli (http://mashable.com/category/martin-shkreli/?utm_campaign=Mash-Prod-RSS-Feedburner-All-Partial&utm_cid=Mash-Prod-RSS-Feedburner-All-Partial), ***** (http://mashable.com/category/*****/?utm_campaign=Mash-Prod-RSS-Feedburner-All-Partial&utm_cid=Mash-Prod-RSS-Feedburner-All-Partial), Allergies (http://mashable.com/category/allergies/?utm_campaign=Mash-Prod-RSS-Feedburner-All-Partial&utm_cid=Mash-Prod-RSS-Feedburner-All-Partial), and Mylan (http://mashable.com/category/mylan/?utm_campaign=Mash-Prod-RSS-Feedburner-All-Partial&utm_cid=Mash-Prod-RSS-Feedburner-All-Partial)http://feeds.feedburner.com/~r/Mashable/~4/gjx_4cYYxp0
http://i.amz.mshcdn.com/DZIeMx5l6kgNKMcTmeo1Y9D1QP0=/575x323/https%3A%2F%2Fblueprint-api-production.s3.amazonaws.com%2Fuploads%2Fcard%2Fima ge%2F189108%2FGettyImages-118451569.jpghttp://a.amz.mshcdn.com/assets/feed-tw-f7c0a094d16b7ee7c91a1e50839a8e00.jpg (http://twitter.com/share?via=Mashable&text=Why+are+EpiPens+so+expensive%2C+and+why+is+ev eryone+so+mad+about+it%3F&url=http%3A%2F%2Fmashable.com%2F2016%2F08%2F24%2Fe pipens-mylan-price-hike%2F%3Futm_campaign%3DMash-Prod-RSS-Feedburner-All-Partial%26utm_cid%3DMash-Prod-RSS-Feedburner-All-Partial)http://a.amz.mshcdn.com/assets/feed-fb-c0a21e8841794479b8086c32c6f24ba1.jpg (http://www.facebook.com/sharer.php?u=http%3A%2F%2Fmashable.com%2F2016%2F08 %2F24%2Fepipens-mylan-price-hike%2F%3Futm_campaign%3DMash-Prod-RSS-Feedburner-All-Partial%26utm_cid%3DMash-Prod-RSS-Feedburner-All-Partial&src=sp)
Over the past few weeks, EpiPens have slowly overtaken the news. So what is going on with them exactly?*
What's happening with EpiPens?*
Last year, Bloomberg broke the story (http://www.bloomberg.com/news/articles/2015-09-23/how-marketing-turned-the-epipen-into-a-billion-dollar-business) that the pharmaceutical company Mylan had turned EpiPens into a cash cow of a business since it bought the product in 2007. In the past few weeks, those claims have come back to public attention.*
Mylan, a huge international pharmaceutical company, has slowly raised the price of EpiPens from an average of $50 in 2007 to more than $300 today (http://www.slate.com/articles/health_and_science/moneybox/2016/07/epipen_costs_have_soared_450_percent_in_the_past_1 2_years_for_**_good_reason.html). Sold only in two-packs —*a**ther change in the past decade — EpiPens can cost (http://www.mylan.com/en/products/product-catalog/product-profile-page?id=6749373C-9FB4-4E2B-A856-3771B31F68F3) as much as $600.* Read more... (http://mashable.com/2016/08/24/epipens-mylan-price-hike/?utm_campaign=Mash-Prod-RSS-Feedburner-All-Partial&utm_cid=Mash-Prod-RSS-Feedburner-All-Partial)
More about Business (http://mashable.com/business/?utm_campaign=Mash-Prod-RSS-Feedburner-All-Partial&utm_cid=Mash-Prod-RSS-Feedburner-All-Partial), Martin Shkreli (http://mashable.com/category/martin-shkreli/?utm_campaign=Mash-Prod-RSS-Feedburner-All-Partial&utm_cid=Mash-Prod-RSS-Feedburner-All-Partial), ***** (http://mashable.com/category/*****/?utm_campaign=Mash-Prod-RSS-Feedburner-All-Partial&utm_cid=Mash-Prod-RSS-Feedburner-All-Partial), Allergies (http://mashable.com/category/allergies/?utm_campaign=Mash-Prod-RSS-Feedburner-All-Partial&utm_cid=Mash-Prod-RSS-Feedburner-All-Partial), and Mylan (http://mashable.com/category/mylan/?utm_campaign=Mash-Prod-RSS-Feedburner-All-Partial&utm_cid=Mash-Prod-RSS-Feedburner-All-Partial)http://feeds.feedburner.com/~r/Mashable/~4/gjx_4cYYxp0